09
May

08:00 AM PDT

Drug Discovery Biology

Strategy Meeting West Coast USA 2022

The premier meeting for all West Coast USA Biology professionals

The Westin St. Francis San Francisco on Union Square

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Biology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Biology professionals from across the West Coast, in San Francisco, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet the 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting.

Sonela Cavicke

Vice President of Discovery Business Development Sai Life Sciences Ltd

Takako Yoshida-Moriguchi

Drug Discovery Scientist and Program Lead Sai Life Sciences

Hicham Alaoui

Chief Scientific Officer Glycomine Inc.

Dr. Alaoui has more than 20 years of experience in a variety of drug discovery and development organizations. Most recently Dr. Alaoui served as Vice President of Biology at Ardelyx where he led a multidisciplinary Research organization consisting of Molecular and Cellular Pharmacology, In vivo Pharmacology and DMPK. Prior to Ardelyx, Dr. Alaoui was the Vice President of Biotherapeutics Research and Development at Codexis and before that Senior Vice President Discovery Biology and co- head of Research at Symic Bio. In these senior leadership roles, Dr. Alaoui was responsible for expanding that company’s pipeline and strategically extending into new therapeutic areas. Dr Alaoui spent several years at Genentech as Director Biochemical and Cellular Pharmacology, ultimately leading a large in vitro pharmacology group dedicated to lead drug discovery and optimization for both biotherapeutic and small molecule programs. Prior to Genentech, he acted as key contributor for driving multiple protein therapeutic candidates into clinical trials, as well as the establishment of novel in vitro and in vivo pharmacology assays through his various R&D leadership positions at Stryker Biotech, VisEn Medical, Neogenesis Pharmaceuticals, and Shire BioChem. Dr. Alaoui earned a Ph.D. in Microbiology and Immunology at McGill University, Montreal, Quebec, Canada, as well as an M.Sc. in Biochemistry from Pierre & Marie Curie Université, Paris, France. Dr. Alaoui has authored numerous peer-reviewed publications, in addition to being named as an inventor on multiple patent applications.

Venita De Almeida

Vice President, Preclinical Development 3T Biosciences

Dr. Venita De Almeida is the Vice President of Program Development at 3T Biosciences in South San Francisco, CA. Venita started her career with her Ph.D. at Northwestern University, where she conducted structure function studies on the GHRH receptor. Venita then did her postdoctoral fellowship at Genentech and was instrumental in demonstrating the anti-tumor activity of multiple biologics that inhibited the Wnt signaling pathway. She continued research in the Oncology department at Genentech, where worked on multiple ADC programs from target validation to identification of development candidates. In 2013, Venita joined Sutro Biopharma and was responsible for setting up preclinical development and led several development programs including the lead clinical program, STRO-002. Venita joined 3T Biosciences in August 2021 where she leads program development.
During her career, Venita has worked on several biologics including fusion proteins, antibodies, ADCs, and bispecifics; and has been involved in numerous INDs and clinical programs.

Russell Bainer

Head, Computational Biology Maze Therapeutics

Tove Tuntland

Global Head, DMPK Ferring Pharmaceuticals

Ryan Potts

Executive Director and Head, Induced Proximity Platform Amgen

Werner Rubas

Vice President, Preclinical Development Sutro Biopharma, Inc.

Werner Rubas, Ph.D. brings to Sutro 30 years of biotech and pharmaceutical industry experience. Formerly, Dr. Rubas was at Nektar Therapeutics for over nine years, most recently as Executive Director in Non-Clinical Pharmacokinetics and Pharmacodynamics. At Nektar, he provided leadership support, directed the generation of data packages for regulatory submissions of NKTR-214, NKTR-358, NKTR-262, and NKTR-255, filed a patent application for an immunotherapeutic tumor treatment method, and provided scientific input on cross-functional teams from research concepts to late-stage development. Prior to Nektar, Dr. Werner was at Roche in Palo Alto, where he was the Associate Director of the Drug Metabolism and Pharmacokinetics group. Additionally, he has been a SPARK advisor at Stanford University since 2010 and lectures classes on Drug Development at UC Berkeley Extension. Dr. Rubas earned his Ph.D. from ETH, Zurich, and received his pharmacy license from the School of Pharmacy at ETH, Zurich.

David Zarling

Chief Executive Officer Colby Pharmaceuticals

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D San Francisco

Drug Discovery Biology

Strategy Meeting West Coast USA 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >The Westin St. Francis San Francisco on Union Square

Fresh Biology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Meet the 2022 Facilitators

Sonela Cavicke

Takako Yoshida-Moriguchi

Hicham Alaoui

Venita De Almeida

Russell Bainer

Tove Tuntland

Ryan Potts

Werner Rubas

David Zarling

Our 2022 Thought Leader

Our 2022 Co-Hosts

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

The Westin St. Francis San Francisco on Union Square